Mirabegron and Valproate sodium drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Mirabegron (mirabegron) and Valproate sodium (valproate sodium). Common drug interactions include hepatitis fulminant among females and colitis among males.

The phase IV clinical study analyzes what interactions people have when they take Mirabegron and Valproate sodium. It is created by eHealthMe based on reports of 19 people who take the same drugs from the FDA, and is updated regularly.

What is Mirabegron?

Mirabegron has active ingredients of mirabegron. It is often used in urge incontinence. eHealthMe is studying from 5,414 Mirabegron users. Check the latest studies of Mirabegron.

What is Valproate sodium?

Valproate sodium has active ingredients of valproate sodium. It is often used in epilepsy. eHealthMe is studying from 24,044 Valproate sodium users. Check the latest studies of Valproate sodium.

On Jul, 10, 2026

19 people who take Mirabegron and Valproate sodium together, and have interactions are studied.

Mirabegron and Valproate sodium drug interactions.

What are the common drug interactions of Mirabegron and Valproate Sodium, by gender? *:

female:

Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)
Inappropriate antidiuretic hormone secretion
Malaise (a feeling of general discomfort or uneasiness)
Metabolic acidosis (body produces too much acid, or when the kidneys are not removing enough acid from the body)
Pneumonia
Septic shock (shock due to blood infection)

male:

Colitis (inflammation of colon)
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Thirst
Vision blurred
Abdominal pain lower
Hyperkalaemia (damage to or disease of the kidney)
Pain
Rectal haemorrhage (bleeding from anus)
Cellulitis (infection under the skin)
Gastrointestinal disorder (functional problems of gastrointestinal tract)

What are the common drug interactions of Mirabegron and Valproate Sodium, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

n/a

40-49:

n/a

50-59:

n/a

60+:

Colitis (inflammation of colon)
Angina unstable (chest pain due to ischemia of the heart muscle- unstable)
Pain
Pneumonia
Rectal haemorrhage (bleeding from anus)
Septic shock (shock due to blood infection)
Hypokinesia (decreased bodily movement)
Pyrexia (fever)
Abdominal pain lower
Hepatitis fulminant (life-threatening condition defined by significantly impaired liver function)

What are the existing conditions these people have? *

Bipolar Disorder (mood disorder): 6 people, 31.58%
Hypertonic Bladder (bladder-storage function that causes a sudden urge to urinate): 2 people, 10.53%
Micturition Urgency (urgency to pass the urine): 2 people, 10.53%
Depression: 2 people, 10.53%
Gastric Ulcer (stomach ulcer): 1 person, 5.26%
Bipolar I Disorder (mood disorder that is characterized by at least one manic or mixed episode): 1 person, 5.26%
Bladder Irritation: 1 person, 5.26%
Cellulitis (infection under the skin): 1 person, 5.26%
Constipation: 1 person, 5.26%
Enlarged Prostate: 1 person, 5.26%

* Approximation only. Some reports may have incomplete information.

Do you take Mirabegron and Valproate sodium?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously